Business EconomyPosted at: Mar 18 2025 5:31PM


Fusion CX acquires Sequential Technology International LLC

Kolkata, Mar 18 (UNI) Fusion CX, involved in providing customer experience (CX) solutions, has acquired Sequential Technology International LLC (STI), a provider of CX services for the telecom and utilities industries.
The acquisition enhances Fusion CX’s market position, expands its global footprint, and boosts its ability to deliver innovative CX solutions, according to a media statement here on Tuesday.
Fusion CX is investing approximately $12M in acquiring and integrating the business.
“We are thrilled to welcome the STI team into the Fusion CX family,” said Pankaj Dhanuka, Co-Founder, Managing Director, and CEO of Fusion CX . “This acquisition enables us to expand our services and deliver value to clients worldwide.”
Headquartered in Bethlehem, Pennsylvania, STI is recognized for its scalable and reliable customer support services. The integration strengthens Fusion CX’s presence in key global locations, including Bethlehem, Manila, Bangalore, Gurugram, and San Salvador.
“This acquisition brings us complementary strengths, significantly enhancing our capabilities in telecom, utilities, and healthcare,” said Kishore Saraogi, Co-Founder, Managing Director, and COO of Fusion CX.
“We are committed to driving innovation and delivering seamless customer experiences across these vital sectors.”
Fusion CX’s President, Andrew Wilmott, will take on the additional responsibility of overseeing the STI business, to ensure a smooth transition and position the organization for growth.
“By combining our vision and tech stack with STI’s capabilities in serving clients in telecom, utilities, and healthcare, we are poised to deliver scalable, and innovative solutions,” said Andrew Wilmott, President of Fusion CX.
"This partnership will build on STI’s remarkable legacy, deliver transformational solutions, and accelerate growth.”
Global investment bank Canaccord Genuity represented STI as the exclusive financial advisor on the transaction.
UNI SJC BD
Please log in to get detailed story.
Tags: #Fusion CX acquires Sequential Technology International LLC
More News

Godrej incorporates subsidiary to enhance financial services presence

14 Jan 2026 | 8:03 PM

Mumbai, Jan 14 (UNI) Godrej Industries Ltd (GIL) has officially announced that it has incorporated a new subsidiary, called Godrej Investment Ltd, as its financial services arm, which will serve as an umbrella holding company for all group financial operations, including its lending businesses.

see more..

Large-Ticket Deals Power Industrial & Warehousing Leasing to 36 9 Mn Sq Ft in 2025: Colliers

14 Jan 2026 | 7:59 PM

Hyderabad, Jan 14( UNI) India’s industrial and warehousing real estate market recorded its strongest performance in recent years, with 36.9 million sq ft of leasing in 2025, registering a 16% year-on-year growth, according to a report released by Colliers India.

see more..

14 Jan 2026 | 7:35 PM

Hyderabad, Jan 14 UNI) : Capital inflows into India’s real estate sector rose sharply in calendar year 2025, reaching an all-time high of USD 14.3 billion, marking a 25 per cent year-on-year growth, according to a latest report ‘ India market Monitor Q4 2025- Investments’ released by CBRE South Asias Pvt Ltd.

see more..

Cyient founder Mohan Reddy receives living leged award by Geospatial World

14 Jan 2026 | 7:18 PM

Hyderabad, Jan 14 (UNI) Cyient, a global Intelligent Engineering solutions company, on Wednesday announced that its Founder Chairman, Dr. B.V.R. Mohan Reddy, has been conferred the ‘Living Legend Award’ by Geospatial World, one of the world’s leading geospatial knowledge organisations.

see more..

Dr Reddy’s launches first to market OTC antihistamine eye drop in US

14 Jan 2026 | 6:54 PM

Hyderabad, Jan 14 (UNI) : Dr. Reddy’s Laboratories on Wednesday announced the first-to-market U.S. launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the generic equivalent of Extra-Strength Pataday® Once-Daily Relief, following approval by the U.S. Food and Drug Administration.

see more..